Neuroone Medical Technologies (NMTC) Research & Development (2017 - 2026)

Neuroone Medical Technologies has disclosed Research & Development across 10 years of filings, most recently posting $1.3 million for Q1 2026.

• Quarterly Research & Development fell 13.26% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 million (up 0.71% YoY) and the FY2025 annual result came in at $5.0 million, down 1.62% from the prior year.
• Research & Development climbed to $1.3 million in Q1 2026, from $1.2 million in the prior quarter.
• Across five years, Research & Development topped out at $1.9 million in Q2 2023 and bottomed at $1.0 million in Q4 2024.
• The 5-year median for Research & Development is $1.3 million (2024), against an average of $1.4 million.
• Year-over-year, Research & Development jumped 54.36% in 2023 and slumped 37.41% in 2024.
• Neuroone Medical Technologies' Research & Development stood at $1.6 million in 2022, then decreased by 5.13% to $1.5 million in 2023, then plunged by 32.44% to $1.0 million in 2024, then advanced by 24.16% to $1.2 million in 2025, then advanced by 5.31% to $1.3 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $1.3 million, $1.2 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.